학술논문

LBA57Overall survival results of ceritinib in ALKi-naïve patients with ALK-rearranged NSCLC (ASCEND-3).
Document Type
Article
Source
Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p. 1 Chart.
Subject
*NON-small-cell lung carcinoma
*MEDICAL sciences
Language
ISSN
0923-7534